Fire at Emcure Pharma's Pune Plant, Operations Temporarily Halted

Published On 2026-02-09 09:11 GMT | Update On 2026-02-09 09:11 GMT

Fire at MKCG Lab Prompts Inspection

Pune: Emcure Pharmaceuticals Limited has informed about a fire incident at its manufacturing facility in Hinjawadi, Pune, Maharashtra. The incident occurred on February 7, 2026, at the utility block of the company's Plant I, and has led to a temporary disruption of operations at the site.

In a regulatory filing made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emcure stated that the cause of the fire is yet to be ascertained. The company noted that the fire has been controlled and no human injuries or casualties have been reported.

Also Read: Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India

The pharmaceutical company said that operations at the affected plant are expected to be disrupted for an estimated period of five to seven days. It added that it is taking all necessary and adequate measures to restore operations at the earliest.

Emcure further clarified that there is adequate insurance coverage for the facility and that intimation has already been given to the insurance company. The company also stated that it is currently assessing the extent of damage caused by the incident but does not expect any material financial impact on its operations.

The company said it will keep the stock exchanges informed about any further developments related to the incident.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Fire at Emcure Pharma's Pune Plant, Operations Temporarily Halted

Similar News

Pharma Stalwarts Join Hands to Launch the Story of Desh Bandhu Gupta, Founder of Lupin

Sigachi Pharma CEO Gets Conditional Bail in Sangareddy Blast Case That Killed 54 Workers

Fake Liv 52, Ibugesic Plus, Cosglo Cream Seized as Bihar DCA Busts Illegal Drug Unit

Pharmacy Store Owner to Be Booked for Abetment After 20-Year-Old Attendant Found Dead in Pune

Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and Biosimilars

Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up 11%

Pharma Firms May Need Prior Approval for Major Drug Changes Under NDCT Draft Amendment